Related Experiment Video
Updated: Mar 9, 2026

03:53
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
586
FOXN1 deficient nude severe combined immunodeficiency
Ioanna A Rota1, Fatima Dhalla2,3
1Developmental Immunology Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Orphanet Journal of Rare Diseases
|January 13, 2017
Summary
Nude severe combined immunodeficiency (SCID) is a rare genetic disorder caused by FOXN1 mutations, leading to absent thymus and severe T-cell deficiency. Early diagnosis and treatment, such as hematopoietic cell or thymus transplantation, are crucial for better patient outcomes.
Area of Science:
- Genetics
- Immunology
- Developmental Biology
Background:
- Nude severe combined immunodeficiency (SCID) is a rare inherited disorder.
- It results from autosomal recessive loss-of-function mutations in the FOXN1 gene.
- FOXN1 is crucial for thymus development and T-cell maturation.
Purpose of the Study:
- To summarize the understanding of nude SCID, focusing on its genetic basis, clinical presentation, and management.
- To highlight the importance of genetic testing for FOXN1 mutations in diagnosis and counseling.
- To discuss therapeutic options and the impact of early intervention on patient prognosis.
Main Methods:
- Review of reported cases and existing literature on nude SCID.
- Genetic analysis for FOXN1 mutations as a diagnostic tool.
- Evaluation of treatment outcomes for hematopoietic cell and thymus transplantation.
Main Results:
- Nine cases reported with a characteristic triad: absent thymus, congenital alopecia universalis, and nail dystrophy.
- FOXN1 mutations are the confirmed cause, leading to severe T-cell immunodeficiency.
- Successful transplantation strategies improve outcomes, while delayed management leads to poor prognosis.
Conclusions:
- Nude SCID is a severe but potentially manageable condition with early diagnosis and intervention.
- Genetic testing for FOXN1 mutations is essential for accurate diagnosis, genetic counseling, and guiding treatment.
- Timely hematopoietic cell or thymus transplantation offers the best chance for improved patient survival and quality of life.

